RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-23.86%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.2B
AUM Growth
+$3.2B
(-27%)
Cap. Flow
-$1.25M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
52.42%
Holding
74
New
3
Increased
14
Reduced
34
Closed
4
Top Buys
| 1 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$37.7M |
| 2 |
Tandem Diabetes Care
TNDM
|
$31.5M |
| 3 |
Centene
CNC
|
$24.2M |
| 4 |
RAPT Therapeutics
RAPT
|
$16.5M |
| 5 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$14.2M |
Top Sells
| 1 |
ICU Medical
ICUI
|
$27.4M |
| 2 |
Genmab
GMAB
|
$26.2M |
| 3 |
UnitedHealth
UNH
|
$26M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$16.2M |
| 5 |
Elevance Health
ELV
|
$13.3M |
Sector Composition
| 1 | Healthcare | 94.94% |
| 2 | Consumer Staples | 2.8% |
| 3 | Industrials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $502M | 15.68% | 12,957,222 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $211M | 6.6% | 22,329,386 -386,700 | -2% | -$3.66M |
|
3
argenx
ARGX
$43.6B
| $163M | 5.08% | 515,943 -5,700 | -1% | -$1.8M |
|
4
LivaNova
LIVN
$3.08B
| $161M | 5.03% | 1,970,511 -86,667 | -4% | -$7.09M |
|
5
Krystal Biotech
KRYS
$4.27B
| $121M | 3.77% | 1,815,698 -5,200 | -0.3% | -$346K |
|
6
Kymera Therapeutics
KYMR
$2.95B
| $111M | 3.45% | 2,615,030 +27,300 | +1% | +$1.16M |
|
7
ADC Therapeutics
ADCT
$345M
| $109M | 3.41% | 7,432,429 -18,600 | -0.2% | -$273K |
|
|
SNCE
8
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $106M | 3.31% | 19,808,234 | – | – |
|
9
Beam Therapeutics
BEAM
$1.66B
| $105M | 3.28% | 1,836,050 -49,800 | -3% | -$2.85M |
|
10
The Beauty Health Co
SKIN
$264M
| $89.5M | 2.8% | 5,304,505 +221,700 | +4% | +$3.74M |
|
|
IGMS
11
DELISTED
IGM Biosciences
IGMS
| $89.1M | 2.78% | 3,334,355 | – | – |
|
12
Celldex Therapeutics
CLDX
$1.47B
| $69.7M | 2.18% | 2,046,269 -119,317 | -6% | -$4.06M |
|
13
Absci
ABSI
$357M
| $67.7M | 2.11% | 8,031,094 | – | – |
|
14
Regenxbio
RGNX
$451M
| $65.6M | 2.05% | 1,976,923 +79,700 | +4% | +$2.65M |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $63.6M | 1.98% | 441,274 +69,435 | +19% | +$10M |
|
16
Replimune Group
REPL
$422M
| $62.7M | 1.96% | 3,691,312 -175,200 | -5% | -$2.97M |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $58M | 1.81% | 6,245,911 -191,866 | -3% | -$1.78M |
|
|
18
Centene
CNC
$14.3B
| $54.6M | 1.71% | 648,837 +287,698 | +80% | +$24.2M |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $43.9M | 1.37% | 9,217,945 +959,600 | +12% | +$4.57M |
|
20
Stoke Therapeutics
STOK
$1.08B
| $42.6M | 1.33% | 2,024,368 -222,300 | -10% | -$4.68M |
|
21
Nurix Therapeutics
NRIX
$714M
| $42.3M | 1.32% | 3,018,784 +60,500 | +2% | +$848K |
|
|
AUGX
22
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $42.3M | 1.32% | 14,380,327 | – | – |
|
|
VERV
23
DELISTED
Verve Therapeutics
VERV
| $41.9M | 1.31% | 1,835,328 +126,792 | +7% | +$2.89M |
|
|
24
Elevance Health
ELV
$71.8B
| $40.9M | 1.28% | 83,162 -27,127 | -25% | -$13.3M |
|
25
Repare Therapeutics
RPTX
$71.7M
| $38.9M | 1.21% | 2,732,996 -56,500 | -2% | -$805K |
|